From opgdjqpzelldjn@apexcgi.com  Sun Apr 10 17:30:45 2005
Return-Path: <opgdjqpzelldjn@apexcgi.com>
Received: from cnq23-162.cablevision.qc.ca (cnq23-162.cablevision.qc.ca [24.212.23.162])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3AMU2Dq015356;
	Sun, 10 Apr 2005 17:30:10 -0500
Received: (qmail 67847 invoked from network); Sun, 10 Apr 2005 22:27:43 -0100
Received: from unknown (HELO qed.benfieldelectric.com) (213.165.64.215)
 by server-9.diophantine-91.acropolis-newyork.com with SMTP; Mon, 11 Apr 2005 03:23:43 +0400
Received: by qed with Internet Mail Service (5.5.4915.04)
	id <WDC52ODJ>; Mon, 11 Apr 2005 05:21:43 +0600
Date: Mon, 11 Apr 2005 04:27:43 +0500
From: "Valentin Nance" <opgdjqpzelldjn@apexcgi.com>
Subject: Spec M0ney Newsletter majOr ch0ice
To: <cypherpunks@al-qaeda.net>
References: <DAP78EFBR9G7EIUX@acropolis-newyork.com>
In-Reply-To: <DAP78EFBR9G7EIUX@acropolis-newyork.com>
Message-ID: <006700109249.NOS63417@qed.abcs-i.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3435
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,000,O00 EST
Current Price: O.09
2OO4 Success lead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint StOck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
90O1 industrial certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Inc|uded in the stable of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Belladonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydroch|orrde, 1O-Deacety| Baccatin, Pac|itaxol, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O0O with a view to become 
a cost effective producer and supplier of bulk Pharmaceutical and 
Neutraceutica| products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a large gr0up of phenolic secondary 
metabo|ites of plants that inc|ude more than 2,0O0 different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modulate the 
permeabi|ity of the wa|ls of the b|ood vessels including capi|laries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to se|l its drug products.

Estimated revenues for 2OO4-2005 are more then  $1OO mi|li0n USD

Further developments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny StOcks are considered highly specu|ative and may be unsuitable 
for all but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 3000 dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.  
 
If you wish to stop future mailings, or if you feel you have been
wrongful|y placed in our membership, p|ease go here or send a b|ank
e mail with No Thanks in the subject to   st0ck66  @yahoo.com

